Unraveling the role of ferroptosis in metabolic dysfunction-associated steatotic liver disease
疾病
医学
脂肪肝
生物信息学
内科学
生物
作者
Cédric Peleman
标识
DOI:10.63028/10067/2122320151162165141
摘要
Up to 45% of patients from biopsy-proven cohorts of metabolic dysfunction-associated steatotic liver disease displayed a signature of ferroptosis or gene expression compatible with heightened susceptibility towards this cell death. While ferroptosis defenses other than glutathione peroxidase 4 became more prominent in a mouse model of metabolic dysfunction-associated steatohepatitis (MASH), i.e., the choline-deficient L-amino acid-defined high-fat diet (CDAHFD), livers in this model displayed cell death with increased ferroptosis breakdown products. Inhibition of ferroptosis in CDAHFD and high-fat high-fructose diet (HFHFD) reduced circulating hepatocyte damage markers and steatosis, but did not impact other histologic abnormalities. In addition, the supplementation of monounsatured fatty acids and saturated fatty acids induced lipid droplet accumulation in HepG2 cells which maintained their ferroptosis sensitivity, possibly through increased phosphatidyglycerol containing two polyunsaturated fatty acid lipid tails and lower expression of ferroptosis defenses.